P01-02: An updated adverse outcome pathway network on chemical-induced liver steatosis by Verhoeven, A., van Ertvelde, J., Boeckmans, J., Gatzios, A., Jover, R., Lindeman, B., Lopez Soop, G., Marcelino Rodrigues, R., Rapisarda, A., Stinckens, M., Sepehri, S., Vinken, M., Jiang, J., Vanhaecke, T.

Get full text

OS02 | Short Orals Session 2: OS02-01Novel clinical phenotypes and chemical classifications in drug-induced cholestasis: analysis of a database of 390 patients developed by collabo... by Moreno Torres, M., Lopez Pascual, E., Rapisarda, A.S., López, G., Bozada Jr, T., Jiang, J., van Ertvelde, J., Steffensen, I.-L., Lindeman, B., Luechtefeld, T., Dirven, H., Vinken, M., Jover, R.

Get full text

OS02-01: Novel clinical phenotypes and chemical classifications in drug-induced cholestasis: analysis of a database of 390 patients developed by collaborative literature review and... by Moreno Torres, M., Lopez Pascual, E., Rapisarda, A.S., López, G., Bozada Jr, T., Jiang, J., van Ertvelde, J., Steffensen, I.-L., Lindeman, B., Luechtefeld, T., Dirven, H., Vinken, M., Jover, R.

Get full text

SOC-VI-08 Physiological maps: a benchmark tool for adverse outcome pathways and a cornerstone for the development of disease ontologies by Staumont, B., Ladeira, L.C.M., Gamba, A., Lesage, R., Verhoeven, A., Jiang, J., Ertvelde, J. van, Barnes, D.A., Janssen, M.J., Kuchovska, E., Berkhout, J., Roodzant, D., Teunis, M., Bozada, T., Luechtefeld, T.H., Jover, R., Vanhaecke, T., Vinken, M., Masereeuw, R., Fritsche, E., Piersma, A.H., Heusinkveld, H.J., Geris, L.

Get full text

P11-09 Physiology-based framework to study chemical-induced cholestasis by Ladeira, L.C.M., Gamba, A., Lesage, R., Ertvelde, J. van, Jiang, J., Verhoeven, A., Roodzant, D., Teunis, M., Jover, R., Vanhaecke, T., Vinken, M., Geris, L., Staumont, B.

Get full text